Found 0 matching trials
Aggression Prevention Training for Caregivers of Persons With Dementia (APT)
NAThis study will evaluate whether a home-based targeted education and skill ...
Location
Multiple Locations
Reducing Aggression Among People With an Intellectual Disability
NAThe study is an randomised controlled trial (RCT) to test whether supplemen...
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
PHASE1This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Location
Honor Health (GIST, mastocytosis, other solid tumors)
Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
PHASE4IDEA is a Phase IV, prospective, randomised, open-label, multicentre clinic...
Location
Multiple Locations
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
PHASE1To find the best dose of ADI-PEG20 that can be given in combination with ca...
Location
MD Anderson Cancer Center
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
PHASE1Subjects on this study have a type of lymph gland cancer called Non-Hodgkin...
Location
Houston Methodist Hospital
Aggressive Incidents in Medical Settings Study
N/AThe purpose of this study is to identify the incidence rate and characteris...
Location
Middlesex Hospital
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
N/AA prostate cancer diagnosis starts a list of events that often leads to fas...
Location
Portland VA Medical Center
Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
PHASE1Primary Outcome Measures:
Area under the curve (AUC) forTQB2303 and rituxi...
Location
Jiangsu Cancer Hospital
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
PHASE2This study is an open-label, multicenter, proof of concept, phase 2 trial. ...
Location
Hopital Henri Mondor